OUR MISSION

 

To equip women’s healthcare providers with advanced AI medical device technologies for the detection of cervical cancer

 

Cervical cancer is the fourth most common cancer affecting women globally and the second most common cancer for women in low resource settings.
Lack of infrastructure, low availability of resources, together with a shortage of trained medical staff have led to limited access to cervical cancer screening and treatment.

 

Improving access to expert care with the EVA System.
Our Enhanced Visual Assessment (EVA) System is an FDA cleared and CE marked mobile colposcope used to visualize the cervix. Combining high-quality optics, secure image and video capture, with HIPAA and GDPR compliant online data management, the EVA System drastically improves accessibility to expert care with its telemedicine and AI clinical decision support capabilities.

 

PARTNERS

 

BOARD OF DIRECTORS

Ronny Ginor, MD

Ronny Ginor, MD

Venture Partner at Orbimed

Ruth Shaber, MD

Ruth Shaber, MD

Founder and President of the Tara Health Foundation

Paul Swinney

Paul Swinney

Co-founder of Tristel plc.

David Levitz

David Levitz

Co-founder of MobileODT

ADVISORS

Liora Bowers

Health Economics

Paul Blumenthal, MD

Cervical Cancer

Stan Lapidus

Founder of Cytyc and Exact

Lee Newcomer, MD

US Payers

Cherissa Jackson

Public Health

Tony Estrella

Global Insurance

Bruce Khan, MD

Gynecology

MANAGEMENT

Executive Team

A solid team made of seasoned medical professionals, technologists and entrepreneurs

Jen Acobas

VP Regulatory

David Levitz

Co-founder

Yaniv Almog

VP R&D

TEAM MobileODT

We are building a world-class digital health company, together. Technologists, doers, dreamers, and changemakers committed to helping dedicated health workers worldwide better serve their communities. 

Pin It on Pinterest